0.140
0.00 (2.19%)
| Penutupan Terdahulu | 0.137 |
| Buka | 0.140 |
| Jumlah Dagangan | 225,751 |
| Purata Dagangan (3B) | 324,772 |
| Modal Pasaran | 39,874,980 |
| Harga / Jualan (P/S) | 1.18 |
| Harga / Buku (P/B) | 2.10 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Aug 2025 - 29 Aug 2025 |
| Margin Keuntungan | -32.78% |
| Margin Operasi (TTM) | -41.67% |
| EPS Cair (TTM) | -0.040 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 27.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 19.43% |
| Nisbah Semasa (MRQ) | 1.84 |
| Aliran Tunai Operasi (OCF TTM) | -7.26 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -4.73 M |
| Pulangan Atas Aset (ROA TTM) | -21.93% |
| Pulangan Atas Ekuiti (ROE TTM) | -49.77% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (AU) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | NOVA EYE FPO [EYE] | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 5.0 |
| Osilator Teknikal | 2.0 |
| Purata | 1.25 |
|
Nova Eye Medical Ltd develops and sells surgical devices for the treatment of glaucoma, a cause of blindness. In addition, the company is involved in the commercialisation of the subthreshold nano-pulse ophthalmic laser, 2RT, for the treatment of retinal disease via the AlphaRET segment. The company's reportable segments are: Glaucoma Surgical Devices and AlphaRET. The majority of its revenue is generated from the Glaucoma Surgical Devices segment, which is involved in the design, manufacture, marketing, and sale of the iTrack, iTrack Advance, and the Molteno3 glaucoma surgical device. These are all single-use surgical devices. Geographically, the company generates maximum revenue from the United States of America, followed by Europe, the Asia Pacific, Other regions, and Australia. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 15.14% |
| % Dimiliki oleh Institusi | 18.28% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |